Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunology of leishmaniasis.

× No keyword cloud information.

69 in total

1. Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Authors: H R Chakkalath; A A Siddiqui; A H Shankar; D E Dobson; S M Beverley; R G Titus
Journal: Infect Immun Date: 2000-02 Impact factor: 3.441

2. UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.

Authors: Siddhartha Kumar Bhaumik; Manoj Kumar Singh; Subir Karmakar; Tripti De
Journal: Glycoconj J Date: 2008-11-13 Impact factor: 2.916

3. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.

Authors: P Tripathi; S Ray; S Sunder; A Dube; S Naik
Journal: Clin Exp Immunol Date: 2006-02 Impact factor: 4.330

4. Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

Authors: E Pinelli; V P Rutten; M Bruysters; P F Moore; E J Ruitenberg
Journal: Infect Immun Date: 1999-01 Impact factor: 3.441

Review 5. Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.

Authors: H Moll; U Ritter; S Flohé; K Erb; C Bauer; C Blank
Journal: Med Microbiol Immunol Date: 1996-02 Impact factor: 3.402

6. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.

Authors: M Soto; J M Requena; L Quijada; M J Perez; C G Nieto; F Guzman; M E Patarroyo; C Alonso
Journal: Clin Exp Immunol Date: 1999-02 Impact factor: 4.330

7. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.

Authors: G S Nabors; J P Farrell
Journal: Infect Immun Date: 1994-12 Impact factor: 3.441

8. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.

Authors: A Satoskar; H Bluethmann; J Alexander
Journal: Infect Immun Date: 1995-12 Impact factor: 3.441

9. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis.

Authors: Jutta Marfurt; Abed Nasereddin; Igor Niederwieser; Charles L Jaffe; Hans-Peter Beck; Ingrid Felger
Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948

Review 10. Leishmaniasis treatment--a challenge that remains: a review.

Authors: Dilvani O Santos; Carlos E R Coutinho; Maria F Madeira; Carolina G Bottino; Rodrigo T Vieira; Samara B Nascimento; Alice Bernardino; Saulo C Bourguignon; Suzana Corte-Real; Rosa T Pinho; Carlos Rangel Rodrigues; Helena C Castro
Journal: Parasitol Res Date: 2008-06 Impact factor: 2.289